Fierce Biotech

  1. Daiichi Sankyo, AstraZeneca's $5B Enhertu follow-up shows early signs of success in breast cancer badams Fri, 05/07/2021 - 10:17
  2. Gene therapy biotech Gyroscope finds unnavigable seas on IPO market aarmstrong Fri, 05/07/2021 - 09:50
  3. Adcomm experts split on whether to approve ChemoCentryx's avacopan ntaylor Fri, 05/07/2021 - 06:49
  4. Galapagos cuts pipeline, targets €150M in savings after setbacks ntaylor Fri, 05/07/2021 - 06:07
  5. Science 37 taps a SPAC to go public, with siteless trial specialist valued at a cool $1B badams Fri, 05/07/2021 - 04:15